FDA Clearance Tracker · P030035-S073
FRONTIER/FRONTIER II FAMILY OF CRT-PS
Last checked: Nov 20, 2026Latest source record: Jul 25, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jul 25, 2011
Approved
Time to decision
343 days
Received Aug 16, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030035-S073
- Device name
- FRONTIER/FRONTIER II FAMILY OF CRT-PS
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Aug 16, 2010
- Decided
- Jul 25, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P030035
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT ST. JUDE MEDICAL OPERTIONS (MY) SDN. BHD. IN BAYAN LEPAS, MALAYSIA.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.